Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
about
Structure of the human histamine H1 receptor complex with doxepinCrystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptorStructure-based discovery of opioid analgesics with reduced side effects.Diversity and modularity of G protein-coupled receptor structuresNew insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptorsRecent developments in adenosine receptor ligands and their potential as novel drugsFunction-specific virtual screening for GPCR ligands using a combined scoring methodDiscovery of novel GPVI receptor antagonists by structure-based repurposingStructural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist bindingDiscovery and cardioprotective effects of the first non-Peptide agonists of the G protein-coupled prokineticin receptor-1In search of novel ligands using a structure-based approach: a case study on the adenosine A2A receptorThe role of experimental and computational structural approaches in 7TM drug discovery.Compound activity prediction using models of binding pockets or ligand properties in 3D.Docking Screens for Novel Ligands Conferring New Biology.Structure-function of the G protein-coupled receptor superfamily.Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists.Ligand discovery from a dopamine D3 receptor homology model and crystal structureStructure-based discovery of A2A adenosine receptor ligands.Structural determinants of PERK inhibitor potency and selectivityStructure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid ReceptorPharmacochemistry of the platelet purinergic receptors.Prediction of ligand binding using an approach designed to accommodate diversity in protein-ligand interactionsSubstructure-based virtual screening for adenosine A2A receptor ligands.Analysis of structure-based virtual screening studies and characterization of identified active compounds.Structure based prediction of subtype-selectivity for adenosine receptor antagonistsALiBERO: evolving a team of complementary pocket conformations rather than a single leader.Significance estimation for sequence-based chemical similarity searching (PhAST) and application to AuroraA kinase inhibitors.Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonistsGPCR ligand-dendrimer (GLiDe) conjugates: future smart drugs?Structural Analysis of Chemokine Receptor-Ligand Interactions.Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models.Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptorStructure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.Fragment-based lead discovery on G-protein-coupled receptors.International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an updateMolecular probes for the A2A adenosine receptor based on a pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine scaffoldStructure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.Computational studies to predict or explain G protein coupled receptor polypharmacologyIn silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.An efficient multistep ligand-based virtual screening approach for GPR40 agonists.
P2860
Q24595968-A7EE1DDB-0BCA-449C-8DE3-4CED01D5D688Q24633082-77EAE7DC-D000-49AD-9F7C-AEC7DDCDE86CQ26331003-E2D0A1B9-A29B-48DA-9441-88456077FB39Q26852976-46FB5B30-D4BB-4885-A6B8-47F9103FE44CQ26991761-D8AADE98-9345-4C3F-B23F-510DD5CB29A6Q27687253-49E815C3-1FD3-4586-9758-49B91494B647Q28276613-2EBD05B7-6F58-4CC0-AB7D-908223C534BCQ28540147-870D018A-06C6-4E00-A089-E3F7F195450EQ28543560-E8532E8F-FCDC-4CB9-9E65-F06B30813509Q28545251-2A38A17D-6716-47B2-A021-9D8F0B81D24BQ28820807-0C782120-A78B-437D-A0D8-3605AABE093FQ30377191-BC8E875A-527F-47C3-9FBD-4ED85DFDF176Q30423071-003A2B06-9A90-40F3-BDC2-C6831F69390FQ30489011-5B7ABA97-527A-404E-BE3F-8C51CADCC122Q30576993-4D2C51BE-1795-43D9-AE28-BD57D61E13EBQ30793386-1184D7D3-CC60-41B0-A36D-C703053B6AE4Q31031038-30DF47A2-696A-4890-A1F6-E9DEEBCCFBE6Q33560239-E5387456-8180-44AC-BA6B-40D9719C7221Q33744382-5E4A39E5-EABF-49B5-889E-E73184940749Q33860286-7DCEFE1D-B4C6-4792-9849-86305725731BQ33869922-5E941EB2-5554-41EA-A070-831A41441371Q34000855-06E8F585-A7E6-451A-AD70-A0893EC0DBC5Q34054895-AA3A9B11-1F6F-4169-B8D6-033B0F4B25A1Q34212790-B6B2D972-0E88-42D0-B302-E89E7647A63BQ34306247-40331423-6453-47DD-92C0-3D34AD66DD89Q34402706-1370A858-0711-4443-A4E5-D2494BBF8BC1Q34454041-82C9A9EA-C4BF-4176-B7B1-CA14F1F58223Q34490693-895BAE32-575B-421B-9A93-61931F87B644Q34548745-0A6A8E20-68F3-4647-A957-A43B5EA064ADQ34550666-1EB8BA9F-51B5-4BEB-AF9B-4D42CEE53E1BQ34561020-7789A69E-C95F-4551-A608-1844BA24F92DQ34619309-894E741B-105A-4814-A912-C66303D830D6Q34676680-FD6716F8-B519-4DE9-858B-227EBDDF4EEAQ34690000-D45EA380-9549-4C53-85CB-EB15E5E86A68Q34701303-966BCF1D-D093-433F-BCDC-02C86A3E65EAQ34850560-1EE95571-8D71-4937-867B-3F4F704369EAQ34983219-0370A6D7-2887-44C3-8947-E6A36FBB247AQ35039998-C0785C89-F0BF-4C51-8A13-0346379A580EQ35057759-8B4B94DE-BCED-4482-ABA0-5E979B69FF3FQ35059345-AF33CF54-C216-4FF9-8B68-8307E9C21593
P2860
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
@ast
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
@en
type
label
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
@ast
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
@en
prefLabel
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
@ast
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
@en
P2093
P2860
P50
P356
P1476
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
@en
P2093
J Robert Lane
Mark Yeager
Raymond C Stevens
P2860
P304
P356
10.1021/JM901647P
P407
P577
2010-02-01T00:00:00Z